Occudo Quantitative Strategies’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$523K Buy
+25,472
New +$432K 0.03% 496
2024
Q3
– Sell
-11,437
Closed -$224K – 807
2024
Q2
$224K Sell
11,437
-4,538
-28% -$94.7K 0.04% 558
2024
Q1
$347K Sell
15,975
-10,765
-40% -$267K 0.06% 422
2023
Q4
$773K Buy
+26,740
New +$715K 0.11% 264
2023
Q3
– Sell
-24,400
Closed -$904K – 1082
2023
Q2
$904K Buy
24,400
+12,862
+111% +$448K 0.09% 367
2023
Q1
$360K Buy
11,538
+4,589
+66% +$148K 0.03% 604
2022
Q4
$207K Buy
+6,949
New +$249K 0.02% 767

Other funds holding FLGT

Occudo Quantitative Strategies's FLGT Position: Q2 2026 in Review

Occudo Quantitative Strategies opened a new position in Fulgent Genetics (FLGT) in Q2 2026: 25,472 shares worth $523K. The stake represents 0.03% of the portfolio and ranks #496 among its holdings. This is a return to the name: Occudo Quantitative Strategies previously reported a position in FLGT as recently as Q2 2024.

Occudo Quantitative Strategies first reported a position in FLGT in Q4 2022 and has held it in 7 quarters since. The position peaked at $904K in Q2 2023. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Occudo Quantitative Strategies held 25,472 shares of Fulgent Genetics worth $523K as of Q2 2026.
  • Fulgent Genetics was a new Occudo Quantitative Strategies position in Q2 2026.
  • Fulgent Genetics made up 0.03% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #496 holding.
  • Occudo Quantitative Strategies first reported a position in Fulgent Genetics in Q4 2022 and has held it in 7 quarters since.
  • Occudo Quantitative Strategies's Fulgent Genetics position peaked at $904K in Q2 2023.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.